Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia

Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia

Abstract Intensive antiplatelet therapy did not reduce recurrent stroke/transient ischaemic attack (TIA) events as compared with guideline treatment in the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial, but did increase the frequency and severity of bleeding. In...

Full description

Bibliographic Details
Main Authors: Lisa J. Woodhouse, Jason P. Appleton, Hanne Christensen, Rob A. Dineen, Timothy J. England, Marilyn James, Kailash Krishnan, Alan A. Montgomery, Anna Ranta, Thompson G. Robinson, Nikola Sprigg, Philip M. Bath
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-38474-2

Internet

https://doi.org/10.1038/s41598-023-38474-2

Similar Items